Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve the Audited Financial ....
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has informed BSE that its Board of Directors will meet on Tuesday, May 27, 2025. The main agenda is to consider, approve, and take on record both the standalone and consolidated audited financial results for the quarter and full year ended March 31, 2025 (Q4 FY25 / FY25). This is a routine regulatory filing under SEBI's Listing Regulations. The company's trading window for insiders remains closed and will stay shut until 48 hours after the results are uploaded to the stock exchanges.
No direct stock price impact — this is only an advance notice of the upcoming results. Investors should watch for the actual Q4 and FY25 numbers on May 27, 2025, which could move the stock depending on performance versus expectations.